Vassilios Papadakis

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

Ruth Ladenstein, Ulrike Pötschger, Andrew D.J. Pearson et al. · The Lancet Oncology · 2017 · 334 citations · Full text

Oncology, Medicine, Versus Carboplatin +8

Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

Ruth Ladenstein, Dominique Valteau‐Couanet, Penelope Brock et al. · Journal of Clinical Oncology · 2010 · 129 citations

Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study

Virginie Viprey, Walter M. Gregory, Maria Valeria Corrias et al. · Journal of Clinical Oncology · 2014 · 119 citations · Full text

Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study

Keith Holmes, Ulrike Pötschger, Andrew D.J. Pearson et al. · Journal of Clinical Oncology · 2020 · 117 citations · Full text

Gonadal function in young patients successfully treated for Hodgkin disease

Vassilios Papadakis, Elpis Vlachopapadopoulou, Karen Van Syckle et al. · Medical and Pediatric Oncology · 1999 · 98 citations